Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinib

Curr Med Res Opin. 2013 Sep;29(9):1075-82

View abstract

Authors

Goldberg SL, Chen L, Guerin A, Macalalad AR, Liu N, Kaminsky M, Ericson SG, Wu EQ